Bayesian Augmented Clinical Trials in TB Therapeutic Vaccination
We propose a Bayesian hierarchical method for combining and data onto an augmented clinical trial with binary end points. The joint posterior distribution from the experiment is treated as a prior, weighted by a measure of compatibility of the shared characteristics with the data. We also formalise...
Saved in:
Published in | Frontiers in medical technology Vol. 3; p. 719380 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
22.10.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | We propose a Bayesian hierarchical method for combining
and
data onto an augmented clinical trial with binary end points. The joint posterior distribution from the
experiment is treated as a prior, weighted by a measure of compatibility of the shared characteristics with the
data. We also formalise the contribution and impact of
information in the augmented trial. We illustrate our approach to inference with
data from the UISS-TB simulator, a bespoke simulator of virtual patients with tuberculosis infection, and synthetic physical patients from a clinical trial. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Reviewed by: Vasileios C. Pezoulas, University of Ioannina, Greece; Daniele E. Schiavazzi, University of Notre Dame, United States Edited by: Giancarlo Pennati, Politecnico di Milano, Italy This article was submitted to Cardiovascular Medtech, a section of the journal Frontiers in Medical Technology |
ISSN: | 2673-3129 2673-3129 |
DOI: | 10.3389/fmedt.2021.719380 |